OCCL Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

OCCL (NSE: OCCL) is preparing to announce its Q4 FY26 financial results for the quarter ended March 31, 2026. With OCCL trading at Rs 1,450 — against a 52-week high of Rs 2,100 and a 1-year return of -20% — the Q4 FY26 results will be a pivotal event for investors in the Specialty Chemicals sector.

Analyst estimates for Q4 FY26 revenue stand at Rs 220–250 Cr, with PAT expectations of Rs 22–28 Cr and margin projections of EBITDA 16–19%. This article covers the OCCL Q4 results 2026 date, detailed earnings estimates, five key performance factors, five risks to monitor, analyst ratings and price targets, and answers to the most commonly searched investor questions.

Get free investment predictions and live Q4 result alerts on Univest.

OCCL Q4 Results 2026 Date

OCCL has scheduled its Q4 FY26 results for May 2026 (Expected). The board of directors will meet on this date to approve the audited financial statements for the quarter ended March 31, 2026, and to consider a final dividend recommendation. At a current market price of Rs 1,450, investors and analysts are closely watching this announcement for revenue growth confirmation and FY27 guidance.

Why This Quarter Matters

Q4 is the final quarter of the financial year — it determines full-year FY26 performance, sets the FY27 estimate base, and triggers final dividend announcements. For OCCL, which operates in the Specialty Chemicals sector, Q4 FY26 will reveal whether momentum from earlier quarters has been sustained and whether management’s strategic initiatives have translated into financial outcomes.

At a 1-year return of -20%, this quarter’s results and FY27 guidance will be critical in determining whether the stock can begin a recovery. Investors will watch for order pipeline updates, margin trajectory, and capex guidance — any positive surprise on multiple parameters could drive a meaningful post-results re-rating.

OCCL Q4 FY26 Earnings Estimates

OCCL Q4 FY26 Analyst Estimates at a Glance | Source: MOFSL, YES Securities, JM Financial

Access premium SEBI-registered research on Univest.

Analysts covering OCCL have published Q4 FY26 estimates based on Q3 FY26 actuals, sector trends, and company-specific catalysts. Consensus estimates point to revenue of Rs 220–250 Cr, PAT of Rs 22–28 Cr, and margins of EBITDA 16–19%. These projections reflect both the seasonal strength of Q4 and ongoing structural improvements in OCCL’s business model.

Beyond headline numbers, investors will closely monitor FY27 guidance commentary, order book evolution, working capital trends, and any one-time items that could inflate or suppress reported PAT. A clean recurring profit print is more positively received by the market than results driven by non-operational gains.

Screen OCCL fundamentals on Univest Screener.

5 Key Factors That Will Drive OCCL Q4 FY26 Performance

Agrochemical Intermediate Demand Recovery

OCCL manufactures specialty organic chemicals primarily for agrochemical applications. Q4 FY26 represents the pre-kharif season restocking period in India, driving demand for agrochemical intermediates. Global agrochemical destocking — which pressured revenues through FY25-26 — appears to be normalising, and any positive commentary from management on order pipeline would be a strong positive catalyst.

Export Revenue and European Demand

OCCL derives 35–40% of revenues from exports, primarily to European and US agrochemical companies. The post-destocking recovery in European agrochemical markets is expected to drive export growth in Q4 FY26. Currency tailwinds from a weaker rupee also support export competitiveness and realisation in rupee terms.

New Product Commercialisation

OCCL has been investing in new specialty chemical products beyond its core agrochemical intermediate business. Q4 FY26 results will reflect initial contributions from newer product lines. Successful commercialisation of high-margin new products would de-risk revenue concentration and support premium valuation multiples.

EBITDA Margin Expansion

Q4 FY26 is expected to see EBITDA margin recovery to 16–19% from Q3’s 16.2%, driven by better capacity utilisation and improved product mix. Any beat on margins would be particularly well-received given sector-wide cost pressure and the company’s relative small size — smaller companies benefit disproportionately from operating leverage.

Raw Material Cost Stability

OCCL’s key raw materials include specialty organic chemicals and petrochemical derivatives. Relatively stable crude oil and feedstock prices in Q4 FY26 compared to previous periods should support gross margin improvement. Analyst models assume modest raw material cost tailwinds in their Q4 estimates.

5 Risks to Watch in OCCL Q4 FY26

Agrochemical Sector Pricing Pressure

Despite destocking normalisation, agrochemical pricing globally remains under pressure due to Chinese competition. Any reversal in pricing could delay OCCL’s margin recovery story.

Customer Concentration Risk

OCCL depends on a limited number of global agrochemical customers. Loss of a major customer or reduction in order size from key clients could materially impact Q4 revenues.

Environmental and Regulatory Compliance

Specialty chemical manufacturers face increasing environmental regulations. Any compliance issues, plant shutdowns, or regulatory actions would severely impact production and revenues.

Foreign Exchange Risk

With 35–40% export revenues, OCCL is exposed to currency risk. A sharp rupee appreciation would reduce export realisations in domestic currency terms and compress margins.

Capacity Utilisation Risk

If demand recovery is slower than anticipated, OCCL may not achieve the capacity utilisation levels required to deliver the margin expansion embedded in Q4 FY26 estimates.

OCCL Share Price and Analyst Ratings

OCCL Share Price & Analyst Ratings | Source: NSE/BSE, Broker Notes

OCCL is trading at Rs 1,450 as of early April 2026, against a 52-week high of Rs 2,100 and 52-week low of Rs 1,200. Market cap stands at Rs 1,580 Cr. The 1-year return of -20% reflects sector headwinds alongside company-specific factors. Analyst price targets range from the conservative to the optimistic, reflecting differing views on the pace of business recovery and margin expansion.

Download the Univest iOS App or Univest Android App to track OCCL’s live price and receive real-time Q4 result alerts.

Conclusion

OCCL’s Q4 FY26 results come at a critical juncture — agrochemical destocking appears to be normalising and export markets are recovering. At Rs 1,450, the stock is 31% below its 52-week high of Rs 2,100, suggesting significant re-rating potential if Q4 numbers confirm the recovery narrative. Management commentary on order visibility for Q1 FY27 will be the key catalyst. Consult a SEBI-registered advisor before investing.

This content is published by Univest, a SEBI-registered research and advisory platform. All analyst estimates and price targets cited are from publicly available broker notes. Past performance is not indicative of future results. Investors should conduct independent due diligence before making any investment decisions.

For more Q4 FY26 previews across IT, banking, auto, pharma, and cement sectors, visit Univest Blogs.

Frequently Asked Questions

What is the OCCL Q4 results 2026 date?

OCCL Q4 FY26 results are scheduled for May 2026 (Expected). The board of directors will meet on this date to approve the audited financial statements and consider a dividend recommendation for FY26.

What is the OCCL Q4 FY26 PAT estimate?

Analysts estimate OCCL Q4 FY26 net profit (PAT) in the range of Rs 22–28 Cr. This estimate is based on revenue assumptions of Rs 220–250 Cr and a margin of EBITDA 16–19%. Actual results may differ from these consensus estimates.

What is OCCL’s share price ahead of Q4 results?

OCCL shares are trading at approximately Rs 1,450 as of early April 2026. The 52-week high is Rs 2,100 and the 52-week low is Rs 1,200. The one-year return is -20% and the market cap stands at Rs 1,580 Cr.

Will OCCL declare a dividend in Q4 2026?

OCCL is expected to consider a dividend of Rs 3–5 per share at the Q4 FY26 board meeting on May 2026 (Expected). The quantum signals management’s confidence in free cash flow generation for FY26.

Which analysts have a Buy rating on OCCL?

MOFSL (target Rs 1,800), YES Securities (target Rs 1,900) have positive ratings on OCCL ahead of Q4 FY26 results.

What were OCCL Q3 FY26 results?

In Q3 FY26, OCCL reported revenue of Rs 198 Cr and PAT of Rs 18 Cr, with margins at EBITDA 16.2%. These numbers provided the base for Q4 FY26 estimates and analyst coverage updates.

When do Infosys and TCS announce Q4 results 2026?

TCS announced Q4 FY26 results on April 9, 2026. See the full TCS Q4 Results 2026 preview. Infosys announced Q4 FY26 results on April 23, 2026.

Is OCCL a good investment ahead of Q4 results?

OCCL at Rs 1,450 offers a risk-reward that depends on Q4 execution and FY27 guidance. Investors should review the analyst estimates, monitor the results announcement, and consult a SEBI-registered advisor before making investment decisions. Past performance is not indicative of future results.

Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All financial data and analyst estimates are sourced from publicly available information including NSE/BSE filings and company investor relations pages. Verify all numbers before investing. Consult a SEBI-registered advisor before making investment decisions.

Recent Article

Motisons Jewellers Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Motilal Oswal Financial Services Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Moschip Technologies Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Morepen Laboratories Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Morarjee Textiles Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook